Next Post

ProMIS Files Management Information Circular in Connection with Annual General and Special Meeting of Shareholders

ProMIS Neurosciences Inc. TORONTO, Ontario and CAMBRIDGE, Massachusetts, April 07, 2022 (World NEWSWIRE) — ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or the “Corporation”), is happy to announce it has mailed the See of Observe-and-Access (the “N&A Notice”) to shareholders of file of the Corporation as of April 01, […]